Pediatric Rhabdomyolysis Treatment & Management

  • Author: Eyal Muscal, MD; Chief Editor: Lawrence K Jung, MD   more...
 
Updated: Apr 27, 2010
 

Medical Care

The inciting cause of rhabdomyolysis must be identified and corrected.[34] Expansion of extracellular volume is the cornerstone of treatment. Other supportive measures include correction of electrolyte imbalances.[6, 35] No randomized trials of fluid repletion regimens in any age-group have been done.[7] Few studies on these treatments in children are available.[8]

Aggressive and early hydration with isotonic sodium chloride solution is important for the prevention of pigment-associated renal failure. The composition of repletion fluid is controversial and may also include sodium bicarbonate. Initial fluid use in young children has been recommended at 20 mL/kg and 1-2 L/h in adolescents. Subsequent hydration 2-3 times maintenance may be sufficient.[8, 36]

Insert a Foley catheter for careful monitoring of urine output. Obtain an ECG to monitor effects of hyperkalemia and other electrolyte disturbances. Alkalinization of urine is believed to be helpful and is based on the observation that acidic urine is necessary to cause acute tubular necrosis (ATN). Some authorities believe that aggressive hydration sufficiently causes a solute diuresis that alkalinizes the urine. Mannitol is often used to induce diuresis in adult patients. Its efficacy has not been adequately compared with that of aggressive hydration regimens.[11, 37, 7]

Sodium bicarbonate is used with care to prevent metabolic acidosis because it may potentiate hypocalcemia. Intravenous bicarbonate concentration is often adjusted to achieve a urine pH level of more than 6.5. This level of alkalinization inhibits precipitation of myoglobin and hemoglobin in the tubules.

Ferrihemate and globin are the breakdown products of myoglobin when pH levels fall to less than 5.6. Ferrihemate is one of the agents responsible for ATN. It contains iron, a transition element, which is free to accept and donate electrons. This results in the generation of free radicals, which cause direct renal cell injury. Heme-proteins may also affect nitrous oxide (NO), endothelin receptors, and cytokines.[11]

Frequently monitor serum electrolyte levels, urine pH levels, and acid-base status. Metabolic abnormalities should also be addressed. Treat hyperkalemia by administering insulin and glucose, a nebulized beta agonist, and a potassium exchange resin. These measures transiently shift potassium from extracellular to intracellular compartments.[8, 33]

Correct hypocalcemia only if the patient has cardiac dysrhythmias or seizures. Calcium may combine with phosphate, forming a metastatic calcification, often intramuscularly. Control hyperphosphatemia using alkaline diuresis. Hypercalcemia may develop during the recovery phase.

If urine output is adequate, consider the use of diuretics such as mannitol (in adults) and furosemide. Mannitol, acting as an osmotic diuretic, is thought to increase urinary flow and reduce myoglobin cast obstruction in renal tubules.[6]

Dialysis may be required in patients with oliguric renal failure, persistent hyperkalemia, other electrolyte abnormalities, pulmonary edema, congestive heart failure, and persistent metabolic acidosis.

The role of free-radical scavengers and antioxidants in rhabdomyolysis (eg, pentoxifylline, vitamin E and vitamin C) has been studied in animal models of ischemia-reperfusion injuries. Controlled studies evaluating the efficacy of these agents have not been performed, and their clinical use remains unclear.[11, 7]

Next

Surgical Care

Surgical care may be necessary, depending on the cause of rhabdomyolysis.[6] Measure compartment pressures and perform a fasciotomy if pressures are high (>30 mm Hg). Limb fractures may require surgical and orthopedic treatment.[38]

Previous
Next

Consultations

The following consultations may be indicated:

  • Consult a nephrologist for patients who have significant rhabdomyolysis, show evidence of renal failure, or require dialysis.
  • Consult a neurologist for patients with status epilepticus or newly onset seizures.
  • Consult an orthopedic surgeon for patients with a limb fracture or compartment syndrome.
  • Notify the poison control center in cases of overdose or snake/insect envenomation.
  • Consult a rheumatologist for patients with suspected inflammatory myopathies, systemic lupus erythematosus, or sarcoidosis.
  • Consult a geneticist and metabolism specialist for patients with genetic or metabolic abnormalities. Diagnosis of inborn errors of metabolism and prompt metabolic interventions may be life saving.
Previous
Next

Diet

Dietary modification may help to reduce the symptoms associated with some of the metabolic disorders and inborn errors of metabolism.[9] Dietary supplementation with glucose or fructose may decrease the pain and fatigue associated with phosphorylase deficiency. The muscle pain and myoglobinuria due to carnitine palmityl transferase deficiency may be reduced with frequent meals and a low-fat, high-carbohydrate diet. Substitution of medium-chained triglycerides may also be helpful. Dietary modification does not seem to change the muscle symptoms of phosphofructokinase deficiency or phosphoglycerate mutase deficiency.

Previous
Next

Activity

Strenuous activities (eg, competitive sports) should be avoided if they cause recurrent myalgias, myopathy, or rhabdomyolysis.[9] Children and adolescents with recurrent rhabdomyolysis related to exertion require further medical evaluation.

High-school coaches and trainers must ensure proper hydration and maintain fluid balance during practice sessions and games. Signs and symptoms of heat exhaustion must be evaluated in a timely fashion during hot and humid conditions.[15]

Alcohol abuse should be stopped. Use of narcotics and sedative hypnotics should be avoided, and inciting prescribed medications must be stopped.

Previous
Proceed to Medication
 
 
Contributor Information and Disclosures
Author

Eyal Muscal, MD  Assistant Professor, Section of Pediatric Rheumatology, Department of Pediatrics, Baylor College of Medicine, Texas Children's Hospital

Eyal Muscal, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Rheumatology, and Clinical Immunology Society

Disclosure: Nothing to disclose.

Coauthor(s)

Marietta Morales DeGuzman, MD  Assistant Professor, Department of Pediatrics, Baylor College of Medicine; Consulting Staff, Section of Pediatric Rheumatology, Department of Pediatrics, Texas Children's Hospital, Ben Taub General Hospital

Marietta Morales DeGuzman, MD is a member of the following medical societies: American Academy of Pediatrics, American College of Rheumatology, and Texas Pediatric Society

Disclosure: Nothing to disclose.

Specialty Editor Board

Barry L Myones, MD  Associate Professor, Departments of Pediatrics and Immunology, Pediatric Rheumatology Section, Baylor College of Medicine; Director of Research, Pediatric Rheumatology Center, Texas Children's Hospital

Barry L Myones, MD is a member of the following medical societies: American Academy of Pediatrics, American Association of Immunologists, American College of Rheumatology, American Heart Association, American Society for Microbiology, Clinical Immunology Society, and Texas Medical Association

Disclosure: Nothing to disclose.

Mary L Windle, PharmD  Adjunct Associate Professor, University of Nebraska Medical Center College of Pharmacy; Editor-in-Chief, Medscape Drug Reference

Disclosure: Nothing to disclose.

Herbert S Diamond, MD  Adjunct Professor of Medicine, Division of Rheumatology, University of Pittsburgh School of Medicine; Chairman Emeritus, Department of Internal Medicine, Western Pennsylvania Hospital

Herbert S Diamond, MD is a member of the following medical societies: Alpha Omega Alpha, American College of Physicians, American College of Rheumatology, American Medical Association, and Phi Beta Kappa

Disclosure: Merck Ownership interest Other; Smith Kline Ownership interest Other; Zimmer Ownership interest Other

Daniel Rauch, MD, FAAP  Director, Pediatric Hospitalist Program, Associate Professor, Department of Pediatrics, New York University School of Medicine

Daniel Rauch, MD, FAAP is a member of the following medical societies: Ambulatory Pediatric Association, American Academy of Pediatrics, and Society of Hospital Medicine

Disclosure: Baxter Honoraria Consulting

Chief Editor

Lawrence K Jung, MD  Chief, Division of Pediatric Rheumatology, Children's National Medical Center

Lawrence K Jung, MD is a member of the following medical societies: American Association for the Advancement of Science, American Association of Immunologists, American College of Rheumatology, Clinical Immunology Society, and New York Academy of Sciences

Disclosure: Nothing to disclose.

Additional Contributors

The authors and editors of eMedicine gratefully acknowledge the contributions of previous authors Renee Wilson, MD, and Binita R Shah, MD, FAAP, to the original writing and development of this article.

References
  1. Beetham R. Biochemical investigation of suspected rhabdomyolysis. Ann Clin Biochem. 2000;37:581-587. [Medline].

  2. Mannix R, Tan ML, Wright R, Baskin M. Acute pediatric rhabdomyolysis: causes and rates of renal failure. Pediatrics. Nov 2006;118(5):2119-25. [Medline].

  3. Cervellin G, Comelli I, Lippi G. Review: Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features. Clin Chem Lab Med. Mar 19 2010;[Medline].

  4. Gabow PA, Kaehny WD, Kelleher SP. The spectrum of rhabdomyolysis. Medicine (Baltimore). May 1982;61(3):141-52. [Medline].

  5. Watemberg N, Leshner RL, Armstrong BA, Lerman-Sagie T. Acute pediatric rhabdomyolysis. J Child Neurol. Apr 2000;15(4):222-7. [Medline].

  6. Vanholder R, Sever MS, Erek E, Lameire N. Rhabdomyolysis. J Am Soc Nephrol. Aug 2000;11(8):1553-61. [Medline]. [Full Text].

  7. Bosch X, Poch E, Grau JM. Rhabdomyolysis and acute kidney injury. N Engl J Med. Jul 2 2009;361(1):62-72. [Medline].

  8. Luck RP, Verbin S. Rhabdomyolysis review of clinical presentation, etiology, diagnosis and management. Pediatr Emerg Care. 2008;24:262-8. [Medline].

  9. Brumback RA, Feeback DL, Leech RW. Rhabdomyolysis in childhood. A primer on normal muscle function and selected metabolic myopathies characterized by disordered energy production. Pediatr Clin North Am. Aug 1992;39(4):821-58. [Medline].

  10. Sitprija V. Animal toxins and the kidney. Nat Clin Pract Nephrol. Nov 2008;4(11):616-27. [Medline].

  11. Huerta-Alardín AL, Varon J, Marik PE. Bench-to-bedside review: Rhabdomyolysis -- an overview for clinicians. Crit Care. Apr 2005;9(2):158-69. [Medline]. [Full Text].

  12. Paller MS. Hemoglobin- and myoglobin-induced acute renal failure in rats: role of iron in nephrotoxicity. Am J Physiol. Sep 1988;255(3 Pt 2):F539-44. [Medline].

  13. Melli G, Chaudhry V, Cornblath DR. Rhabdomyolysis: An Evaluation of 475 Hospitalized Patients. Medicine. 2005;84 (6):377-385. [Medline].

  14. Chamberlain MC. Rhabdomyolysis in children: a 3-year retrospective study. Pediatr Neurol. May-Jun 1991;7(3):226-8. [Medline].

  15. Bergeron MF, McKeag DB, Casa DJ, et al. Youth Football: Heat Stress and Injury Risk. Med Sci Sports Exerc. 2005;37 (8):1421-1430. [Medline].

  16. Hall AP, Henry JA. Acute toxic effects of 'Ecstasy' (MDMA) and related compounds: overview of pathophysiology and clinical management. Br J Anaesth. Jun 2006;96(6):678-85. [Medline].

  17. Coco TJ, Klasner AE. Drug-induced rhabdomyolysis. Curr Opin Pediatr. Apr 2004;16(2):206-10. [Medline].

  18. Singh U, Scheld WM. Infectious etiologies of rhabdomyolysis: three case reports and review. Clin Infect Dis. Apr 1996;22(4):642-9. [Medline].

  19. Lofberg M, Jankala H, Paetau A, et al. Metabolic causes of recurrent rhabdomyolysis. Acta Neurol Scand. Oct 1998;98(4):268-75. [Medline].

  20. Knochel JP. Hypophosphatemia and rhabdomyolysis. Am J Med. May 1992;92(5):455-7. [Medline].

  21. Pedrozzi NE, Ramelli GP, Tomasetti R, et al. Rhabdomyolysis and anesthesia: a report of two cases and review of the literature. Pediatr Neurol. Oct 1996;15(3):254-7. [Medline].

  22. Hollander AS, Olney RC, Blackett PR, Marshall BA. Fatal malignant hyperthermia-like syndrome with rhabdomyolysis complicating the presentation of diabetes mellitus in adolescent males. Pediatrics. 2003;111:1447-1452. [Medline]. [Full Text].

  23. Graham DJ, Staffa JA, Shatin D et al. Incidence of hospitalized rhabdomyolysis in patients treated with lipid lowering-drugs. JAMA. 2004;292:2585-2590. [Medline].

  24. Thompson PD, Clarkson P, Karas RH. Statin-associated myopathy. JAMA. Apr 2 2003;289(13):1681-90. [Medline].

  25. Urso ML, Clarkson PM, Hittel D, Hoffman EP, Thompson PD. Changes in ubiquitin proteasome pathway gene expression in skeletal muscle with exercise and statins. Arterioscler Thromb Vasc Biol. Dec 2005;25(12):2560-6. [Medline]. [Full Text].

  26. Joy TR, Hegele RA. Narrative review: statin-related myopathy. Ann Intern Med. Jun 16 2009;150(12):858-68. [Medline].

  27. Wiegman A, Hutten BA, de Groot E, et al. Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial. JAMA. Jul 21 2004;292(3):331-7. [Medline].

  28. Hurley JK. Severe rhabdomyolysis in well conditioned athletes. Mil Med. May 1989;154(5):244-5. [Medline].

  29. Sinert R, Kohl L, Rainone T, Scalea T. Exercise-induced rhabdomyolysis. Ann Emerg Med. Jun 1994;23(6):1301-6. [Medline].

  30. Mehta R, Fisher LE Jr, Segeleon JE, Pearson-Shaver AL, and Wheeler DS. Acute rhabdomyolysis complicating status asthmaticus in children: case series and review. Pediatr Emerg Care. 2006;22:587-91. [Medline].

  31. Schwengel D, Ludwig S. Rhabdomyolysis and myoglobinuria as manifestations of child abuse. Pediatr Emerg Care. Dec 1985;1(4):194-7. [Medline].

  32. Peebles J, Losek JD. Child physical abuse and rhabdomyolysis: case report and literature review. Pediatr Emerg Care. Jul 2007;23(7):474-7. [Medline].

  33. Salluzzo R, Schwartz M, ed. Rhabdomyolysis. In: Emergency Clinical Practice. 4th ed. 1998:2478-86.

  34. [Guideline] Finnish Medical Society Duodecim. Rhabdomyolysis. In: EBM Guidelines. Evidence-Based Medicine [Internet]. Helsinki, Finland: Wiley Interscience. John Wiley & Sons; 2007 Apr 12. [Full Text].

  35. Better OS, Stein JH. Early management of shock and prophylaxis of acute renal failure in traumatic rhabdomyolysis. N Engl J Med. Mar 22 1990;322(12):825-9. [Medline].

  36. Gunn VL, Nechyba C, eds. The Harriet Lane Handbook. 16th ed. St Louis, MO: Mosby Elsevier, Inc.; 2002:45.

  37. Brown C, Rhee P, Chan L et al. Preventing renal failure in patients with rhabdomyolysis: do bicarbonate and mannitol make a difference?. J Trauma. 2004;56:1191-1196. [Medline].

  38. Sever MS, Vanholder R, Lameire N. Management of Crush-Related Injuries after Disasters. NEJM. 2006;Volume 354:1052-1063. [Medline].

  39. Thoenes M. Rhabdomyolysis: when exercising becomes a risk. J Pediatr Health Care. May-Jun 2010;24(3):189-93. [Medline].

Previous
Next
 
Model of helical domains in myoglobin, the protein linked to kidney damage in rhabdomyolysis.
 
 
 
All material on this website is protected by copyright, Copyright © 1994-2012 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

DISCLAIMER: The content of this Website is not influenced by sponsors. The site is designed primarily for use by qualified physicians and other medical professionals. The information contained herein should NOT be used as a substitute for the advice of an appropriately qualified and licensed physician or other health care provider. The information provided here is for educational and informational purposes only. In no way should it be considered as offering medical advice. Please check with a physician if you suspect you are ill.